Opportunities in continuous manufacturing of large molecules
This Pharmaceutical Engineering article briefly reviews continuous biomanufacturing at a time of very high and global demand for vaccines, as well as increased demand for cell and gene therapy products.
US FDA paper on safe continuous production of therapeutic proteins
Building on 20 years of research, the US Food and Drug Administration has published a paper to shed light on how therapeutic proteins can be safely produced on a continuous manufacturing line.
Cytiva and Mycenax to set up Taiwan’s first continuous manufacturing development lab
US life science group Cytiva is collaborating with Mycenax Biotech to establish Taiwan’s first continuous manufacturing process development satellite laboratory. Located at Mycenax’s laboratory in Zhubei, the facility will expand Mycenax’s development capability of continuous process technology.
Pharma’s shift towards a circular economy
This article on pharmamanufacturing.com mentions how flow chemistry in drug discovery and the early stages of drug development has also enabled the exploitation of greener reactions with far higher efficiency and less waste.